BPIRY yields 103.93% · JNJ yields 2.13%● Live data
📍 BPIRY pulled ahead of the other in Year 1
Combined, BPIRY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BPIRY + JNJ for your $10,000?
Piraeus Financial Holdings S.A. provides banking products and services in Greece and internationally. It operates through Retail Banking, Corporate Banking, Piraeus Financial Markets, and Other segments. The company offers time, structured, deposit, saving, current, and business accounts; mortgage, consumer, personal, home improvement, farming, restructuring, and working capital loans; overdrafts; credit, debit, contract farming, and prepaid cards; mutual funds, treasury bonds, equities, dual currency deposits, treasury interest-bearing notes, asset management solutions, and gold sovereigns and gold bars; and car, home, civil liability, health, endowment, accident/life, lifestyle, agricultural, photovoltaic park, trade credit, business premises, and corporate insurances. It also provides financial planning, payment/remittance, bills of exchange collection, cash management, import-export settlement, payroll, foreign exchange, risk management, letters of guarantee, factoring, leasing, and Web banking services. The company offers infrastructure advisory, project and real estate finance, remote banking service, group life and health and electronic and cyber risks insurance programs, debt collection, and contract farming. It operates 414 branches in Greece and another 16 branches in 2 countries. Piraeus Financial Holdings S.A. was formerly known as Piraeus Bank S.A. The company was founded in 1916 and is based in Athens, Greece.
Full BPIRY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.